GO:0032761 positive regulation of lymphotoxin A production: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032761 describes any process that activates or increases the frequency, rate, or extent of lymphotoxin A (LTA, also known as TNF-beta) production.
• LTA is a key cytokine in the lymphotoxin network that orchestrates type I interferon responses and adaptive immunity.
• Positive regulation of LTA production is critical for lymphoid organogenesis, liver regeneration, and tertiary lymphoid structure formation.
• Dysregulated LTA production is implicated in autoimmune diseases, chronic inflammation, and cancer.
• Key genes involved include LTA itself, LTB, TNFRSF14 (LIGHT), and LTBR, which form complex signaling networks.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of LTA regulatory pathways.
Description
Lymphotoxin A (LTA), also known as tumor necrosis factor-beta (TNF-beta), is a pleiotropic cytokine belonging to the TNF superfamily. It plays a central role in the development and organization of secondary lymphoid organs, regulation of immune responses, and host defense. The Gene Ontology term GO:0032761, positive regulation of lymphotoxin A production, encompasses all biological processes that activate or increase the frequency, rate, or extent of LTA production. Understanding this regulatory process is essential for immunologists studying adaptive immunity, autoimmunity, and inflammatory diseases. LTA is produced primarily by activated T cells, B cells, and innate lymphoid cells, and its expression is tightly controlled at transcriptional and post-transcriptional levels. The lymphotoxin network, including LTA and its homolog LTB, coordinates type I interferon responses and shapes the microenvironment of lymphoid tissues. Dysregulation of LTA production has been linked to autoimmune conditions such as rheumatoid arthritis and multiple sclerosis, as well as to cancer progression and liver pathology. Recent studies have highlighted the importance of LTA in liver regeneration, where T cell-derived lymphotoxin regulates hepatocyte proliferation. Additionally, B cell-mediated maintenance of CD169-positive cells depends on lymphotoxin signaling, further underscoring its broad physiological relevance. The formation of tertiary lymphoid structures in chronic inflammation also relies on lymphotoxin production by immunofibroblasts and immune cells. Given its central role in immunity, the positive regulation of LTA production is a focal point for therapeutic intervention and basic research.
positive regulation of lymphotoxin A production At A Glance
| GO ID | GO:0032761 |
|---|---|
| GO term | positive regulation of lymphotoxin A production |
| Ontology | biological_process |
| Synonym | activation of lymphotoxin A production; positive regulation of LTA production; positive regulation of lymphotoxin-alpha production; positive regulation of TNF-beta production; stimulation of lymphotoxin A production; up regulation of lymphotoxin A production |
| Major function | Increases the frequency, rate, or extent of lymphotoxin A (LTA/TNF-beta) production, a cytokine critical for lymphoid organogenesis, immune responses, and liver regeneration. |
| Related GO terms | regulation of lymphotoxin A production (GO:0032759); lymphotoxin A production (GO:0032758); positive regulation of cytokine production (GO:0001819) |
| Cellular location | Extracellular space; plasma membrane (membrane-bound LTA) |
| Key regulators | T cell receptor signaling, CD40-CD40L, LTβR signaling, NF-κB pathway |
What Is GO:0032761?
GO:0032761, positive regulation of lymphotoxin A production, is a biological process defined as any process that activates or increases the frequency, rate, or extent of lymphotoxin A production. This includes transcriptional activation of the LTA gene, enhanced mRNA stability, increased translation, and post-translational processing that leads to higher levels of secreted or membrane-bound LTA. The term is synonymous with activation of lymphotoxin A production, positive regulation of LTA production, positive regulation of lymphotoxin-alpha production, and positive regulation of TNF-beta production, among others. It is a child of the broader terms 'regulation of lymphotoxin A production' and 'positive regulation of cytokine production'.
Why Is positive regulation of lymphotoxin A production Important in Cell Biology?
The positive regulation of lymphotoxin A production is critically important because LTA is a master cytokine in the lymphotoxin network that bridges innate and adaptive immunity. It governs the development of secondary lymphoid organs, the maintenance of follicular dendritic cells, and the organization of tertiary lymphoid structures in chronic inflammation. Dysregulated LTA production contributes to autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, and to cancer progression. Moreover, LTA is essential for liver regeneration and hematopoietic stem cell self-renewal, making it a target for regenerative medicine. Understanding how LTA production is positively regulated provides insights into immune homeostasis and offers therapeutic opportunities for modulating immune responses.
• LTA is essential for the development and organization of secondary lymphoid organs.
• Positive regulation of LTA production drives type I interferon responses and optimizes adaptive immunity.
• LTA signaling is critical for liver regeneration after injury.
• B cell-mediated maintenance of CD169-positive cells depends on lymphotoxin signaling.
• Tertiary lymphoid structure formation in chronic inflammation requires LTA production.
• Dysregulated LTA production is associated with autoimmune diseases like rheumatoid arthritis and multiple sclerosis.
• LTA/LTβR signaling regulates hematopoietic and leukemia stem cell self-renewal.
• LTA is a potential therapeutic target for inflammatory diseases and cancer.
• Understanding LTA regulation aids in vaccine adjuvant design and immunotherapy.
• CRISPR screens can identify novel regulators of LTA production.
What Happens During positive regulation of lymphotoxin A production?
Transcriptional Activation of the LTA Gene
In simple terms: Signals turn on the LTA gene, leading to more mRNA being made.
The LTA gene is located on chromosome 6 in humans and is transcriptionally activated by various stimuli, including T cell receptor engagement, CD40 ligation, and cytokines such as IL-2 and IL-12. Key transcription factors involved include NF-κB, NFAT, and AP-1, which bind to the LTA promoter and enhancer regions. Activation of these factors downstream of TCR signaling leads to increased LTA mRNA synthesis. Positive regulation of LTA production often involves cooperative interactions between these transcription factors and chromatin remodeling complexes that enhance promoter accessibility.
Post-transcriptional Regulation of LTA mRNA
In simple terms: After mRNA is made, its stability and translation are controlled to fine-tune LTA levels.
LTA mRNA contains AU-rich elements (AREs) in its 3' untranslated region that mediate rapid degradation. Positive regulators can stabilize LTA mRNA by preventing ARE-mediated decay, often through signaling pathways involving p38 MAPK and MK2. Additionally, microRNAs such as miR-125b and miR-146a can negatively regulate LTA, and their inhibition can enhance LTA production. Translational efficiency of LTA mRNA is also modulated by mTOR signaling, which promotes cap-dependent translation.
Post-translational Processing and Secretion
In simple terms: The LTA protein is processed and released from the cell to act on other cells.
LTA is initially synthesized as a membrane-bound precursor that can be cleaved by metalloproteinases to release soluble LTA. It can also form heterotrimers with LTB (LTα1β2) that bind to LTβR, or homotrimers (LTα3) that bind to TNFR1 and TNFR2. Positive regulation of LTA production can occur at the level of protein processing, where increased cleavage or secretion leads to higher extracellular LTA levels. The enzyme ADAM17 (TACE) is involved in shedding membrane-bound LTA.
Feedback and Amplification Loops
In simple terms: Once LTA is produced, it can stimulate more LTA production through positive feedback.
LTA signaling through LTβR activates the non-canonical NF-κB pathway, which induces further expression of LTA and LTB, creating a positive feedback loop. This amplification is critical for the formation of lymphoid follicles and tertiary lymphoid structures. Additionally, LTA can induce the expression of chemokines and adhesion molecules that recruit more immune cells, indirectly promoting further LTA production.
Key Genes Involved in GO:0032761 positive regulation of lymphotoxin A production
The following genes and proteins are key players in the positive regulation of lymphotoxin A production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LTA | Encodes lymphotoxin A (TNF-beta), the cytokine whose production is regulated | Core gene; knockout and overexpression models reveal its function in immunity and autoimmunity |
| LTB | Encodes lymphotoxin beta, forms heterotrimers with LTA | Knockout mice lack lymph nodes; used to study lymphoid organogenesis |
| TNFRSF14 | Encodes LIGHT (HVEM ligand), induces LTA production | Involved in T cell activation and autoimmune diseases |
| LTBR | Lymphotoxin beta receptor, mediates signaling for LTA/LTB | Critical for lymphoid tissue development and liver regeneration |
| NFKB1 | NF-κB subunit, transcription factor for LTA | Regulates LTA transcription; knockout reduces LTA production |
| NFKB2 | Non-canonical NF-κB subunit, activated by LTβR | Essential for lymphoid organogenesis and LTA feedback |
| REL | c-Rel, NF-κB subunit, binds LTA promoter | Required for T cell-dependent LTA expression |
| NFATC1 | Calcineurin-dependent transcription factor | Mediates TCR-induced LTA transcription |
| FOS | AP-1 component, cooperates with NF-κB | Enhances LTA promoter activity |
| JUN | AP-1 component, cooperates with NF-κB | Enhances LTA promoter activity |
| MAPK14 | p38 MAPK, stabilizes LTA mRNA | Inhibition reduces LTA production |
| ADAM17 | Metalloproteinase that sheds membrane LTA | Regulates soluble LTA levels |
| CD40LG | CD40 ligand, induces LTA in B cells | Defects cause hyper-IgM syndrome with impaired LTA production |
| IL12A | IL-12 subunit, induces LTA in T cells | Promotes Th1 responses and LTA production |
| IL12B | IL-12 subunit, induces LTA in T cells | Promotes Th1 responses and LTA production |
| IFNG | Interferon gamma, synergizes with LTA | Enhances LTA-mediated immune responses |
| TNF | Tumor necrosis factor, shares receptors with LTA | Competes with LTA for TNFR binding |
| CD169 | Siglec-1, maintained by lymphotoxin signaling | B cell-mediated maintenance depends on LTA |
How Is positive regulation of lymphotoxin A production Regulated?
The positive regulation of lymphotoxin A production is controlled by multiple signaling pathways. T cell receptor (TCR) signaling activates calcineurin/NFAT and PKC/NF-κB pathways, leading to LTA transcription. CD40-CD40L interactions in B cells also induce LTA production. The non-canonical NF-κB pathway, activated by LTβR, creates a positive feedback loop that amplifies LTA expression. Cytokines such as IL-12 and IFN-γ enhance LTA production in T cells. Post-transcriptionally, p38 MAPK/MK2 signaling stabilizes LTA mRNA, while mTOR promotes its translation. Negative regulators include miR-125b and miR-146a, which target LTA mRNA. Understanding these regulatory mechanisms is essential for therapeutic modulation of LTA in autoimmune and inflammatory diseases.
positive regulation of lymphotoxin A production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LTA | Rheumatoid arthritis, multiple sclerosis | LTA knockout mice; overexpression in T cells |
| LTBR | Liver regeneration, lymphoid organogenesis | Liver-specific LTBR knockout; partial hepatectomy model |
| TNFRSF14 | Leukemia stem cell self-renewal | LIGHT knockout or overexpression in hematopoietic stem cells |
| CD169 | Liver regeneration, immune tolerance | CD169-DTR mice; B cell-specific lymphotoxin knockout |
| LTB | Tertiary lymphoid structure formation | Immunofibroblast-specific knockout; chronic inflammation models |
Autoimmune Diseases
Dysregulated positive regulation of LTA production contributes to autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. LTA promotes the formation of tertiary lymphoid structures and the production of pro-inflammatory cytokines, exacerbating tissue damage. Genome-wide association studies have linked LTA polymorphisms to susceptibility to these diseases. Targeting LTA production or signaling is a therapeutic strategy in autoimmunity.
Liver Regeneration and Disease
T cell-derived lymphotoxin is critical for liver regeneration after partial hepatectomy or injury. Positive regulation of LTA production in T cells promotes hepatocyte proliferation through LTβR signaling. B cell-mediated maintenance of CD169-positive cells in the liver also depends on lymphotoxin, highlighting the role of LTA in liver homeostasis. Dysregulated LTA production may contribute to chronic liver diseases and hepatocellular carcinoma.
Cancer and Hematopoietic Malignancies
LTA and its signaling pathways regulate hematopoietic stem cell self-renewal and differentiation. LIGHT/LTβR signaling, which induces LTA production, is involved in leukemia stem cell maintenance. In the tumor microenvironment, LTA can promote tertiary lymphoid structure formation, which correlates with better prognosis in some cancers. However, chronic LTA production can also drive inflammation-associated carcinogenesis.
From positive regulation of lymphotoxin A production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of LTA knockout on lymphoid organ development? | LTA knockout mouse (conventional or conditional) |
| How does a point mutation in LTA affect its secretion? | CRISPR knock-in of point mutation in LTA gene |
| What is the role of LTA overexpression in autoimmune inflammation? | Transgenic or CRISPR knock-in of LTA under a strong promoter |
| How does tagging LTA with a fluorescent protein affect its trafficking? | CRISPR knock-in of GFP-LTA fusion |
| Which genes regulate LTA production in T cells? | Genome-wide CRISPR knockout library screening |
| How does LTA production change in liver regeneration? | Partial hepatectomy in LTA reporter mice |
How to Study the positive regulation of lymphotoxin A production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | LTA mRNA levels and transcriptome changes | Identifying pathways that regulate LTA transcription |
| ChIP-seq | Transcription factor binding to LTA promoter | Mapping NF-κB, NFAT, AP-1 binding sites |
| ELISA | Soluble LTA protein concentration | Quantifying LTA secretion in culture supernatants |
| Flow cytometry | Intracellular and membrane-bound LTA | Identifying LTA-producing cell subsets |
| Luciferase reporter assay | LTA promoter activity | High-throughput screening of LTA regulators |
| CRISPR knockout screen | Genes required for LTA production | Genome-wide identification of positive regulators |
| CRISPR activation screen | Genes that enhance LTA production | Identifying novel activators of LTA |
| Proteomics | LTA protein interactions and modifications | Mapping the LTA interactome |
Transcriptional Profiling
RNA-seq and microarray analysis can quantify LTA mRNA levels under various conditions. Chromatin immunoprecipitation sequencing (ChIP-seq) identifies transcription factor binding sites on the LTA promoter. ATAC-seq reveals chromatin accessibility changes that regulate LTA transcription.
Protein Detection and Quantification
ELISA and flow cytometry are used to measure soluble and membrane-bound LTA protein levels. Intracellular cytokine staining allows detection of LTA-producing cells. Western blotting can assess LTA protein expression and processing.
Functional Assays
Lymphotoxin bioassays measure LTA activity by its cytotoxic effect on sensitive cell lines. Reporter assays using the LTA promoter linked to luciferase enable high-throughput screening for regulators of LTA production.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify positive and negative regulators of LTA production. These screens typically use a reporter cell line expressing fluorescent LTA or a surface marker under the control of the LTA promoter.
How CRISPR Can Be Used to Study GO:0032761 positive regulation of lymphotoxin A production
Knockout
CRISPR knockout of LTA or its regulators (e.g., NFKB1, LTBR) in cell lines or primary T cells can abolish LTA production, revealing essential genes. Knockout mice generated via CRISPR mimic human deficiencies and are used to study lymphoid organogenesis and autoimmunity.
Point Mutation
CRISPR knock-in of point mutations in the LTA gene (e.g., in the promoter or coding region) can dissect the functional impact of specific variants associated with autoimmune diseases. Such models help determine whether a mutation increases or decreases LTA production.
Knock-in
CRISPR knock-in of reporter genes (e.g., GFP, luciferase) into the LTA locus enables real-time monitoring of LTA production in live cells and animals. Tagged knock-in of LTA with epitope tags facilitates protein purification and interaction studies.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of LTA or its upstream regulators can model chronic LTA production and its consequences in inflammation and cancer. Overexpression models are useful for testing therapeutic inhibitors of LTA signaling.
How EDITGENE Supports positive regulation of lymphotoxin A production Research
Researchers studying positive regulation of lymphotoxin A production-related genes often need to determine whether a candidate gene is causally involved in LTA regulation or merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of lymphotoxin A production research.
Frequently Asked Questions About positive regulation of lymphotoxin A production
What is GO:0032761?
GO:0032761 is a Gene Ontology term for 'positive regulation of lymphotoxin A production', describing any process that activates or increases the frequency, rate, or extent of lymphotoxin A (LTA/TNF-beta) production.
What genes are involved in positive regulation of lymphotoxin A production?
Key genes include LTA, LTB, TNFRSF14 (LIGHT), LTBR, NFKB1, NFKB2, REL, NFATC1, FOS, JUN, MAPK14, ADAM17, CD40LG, IL12A, IL12B, IFNG, and TNF.
How is lymphotoxin A production regulated?
LTA production is regulated transcriptionally by NF-κB, NFAT, and AP-1, post-transcriptionally by mRNA stability and translation, and via feedback loops involving LTβR signaling.
What diseases are associated with lymphotoxin A?
LTA is associated with autoimmune diseases like rheumatoid arthritis and multiple sclerosis, liver regeneration, and hematopoietic malignancies.
What is the role of lymphotoxin A in the immune system?
LTA is critical for lymphoid organ development, type I interferon responses, and adaptive immunity.
How can I study positive regulation of lymphotoxin A production?
Use CRISPR knockout, knock-in, overexpression models, RNA-seq, ChIP-seq, ELISA, flow cytometry, and CRISPR screens.
What are the synonyms for positive regulation of lymphotoxin A production?
Synonyms include activation of lymphotoxin A production, positive regulation of LTA production, positive regulation of TNF-beta production, and upregulation of lymphotoxin A production.
Which cell types produce lymphotoxin A?
LTA is produced primarily by activated T cells, B cells, innate lymphoid cells, and some myeloid cells.
What is the difference between LTA and TNF?
LTA (TNF-beta) and TNF (TNF-alpha) are related cytokines that share receptors but have distinct roles in immunity and inflammation.
How does lymphotoxin A contribute to liver regeneration?
T cell-derived LTA signals through LTβR on hepatocytes to promote proliferation after liver injury.
Conclusion
The positive regulation of lymphotoxin A production (GO:0032761) is a fundamental biological process that controls the availability of a key cytokine in immune regulation, lymphoid organogenesis, and tissue regeneration. Dysregulation of this process contributes to autoimmune diseases, chronic inflammation, and cancer, making it a critical area of research. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE provides comprehensive services to support researchers in dissecting the molecular mechanisms of LTA regulation and translating these findings into clinical applications.
References
- 1. Gommerman JL et al.. 2014. The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity.. Cytokine Growth Factor Rev 25(2):139-45 PMID: 24698108
- 2. O'Garra A et al.. 1997. CD4+ T-cell subsets in autoimmunity.. Curr Opin Immunol 9(6):872-83 PMID: 9492992
- 4. O'Garra A et al.. 1993. T-cell subsets in autoimmunity.. Curr Opin Immunol 5(6):880-6 PMID: 7905272
- 5. Behnke K et al.. 2018. B Cell-Mediated Maintenance of Cluster of Differentiation 169-Positive Cells Is Critical for Liver Regeneration.. Hepatology 68(6):2348-2361 PMID: 29742809
- 6. Tumanov AV et al.. 2009. T cell-derived lymphotoxin regulates liver regeneration.. Gastroenterology 136(2):694-704.e4 PMID: 18952083
- 7. Nayar S et al.. 2019. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.. Proc Natl Acad Sci U S A 116(27):13490-13497 PMID: 31213547
- 8. Höpner SS et al.. 2021. LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.. Nat Commun 12(1):1065 PMID: 33594067
